Health Archive » December, 2010

Health - December, 2010

177 articles

• Health Care Regulation To Watch In 2011
• Considering New Expert Disclosure Requirements
• Fed. Circ. Nixes Deal In Sun Pharma Eloxatin Suit
• Genentech Fights FDA's Downgrade Of Avastin
• SEC Sues InterMune Options Buyers Over Inside Tips
• Consumers Lose 2nd Class Cert. Bid In Quest Fight
• Pfizer Yanks More Lipitor After Odor Problems
• FDA Announces Recall Of Abbott Diabetic Test Strips
• RyMed To Fight Infringement Verdict Over IV Patents
• US Joins Qui Tam Suit Over Mayo Medicare Claims
• Ex-UBS Banker Pleads Guilty To Insider Trading Scheme
• Defeating Joinder In Medical Device And Drug Cases
• Sales Reps Hit Daiichi Sankyo With FLSA Action
• 6th Circ. Asked To Rehear Blue Cross ERISA Action
• Obama Inks $250B Short-Term Funding Bill
• Odyssey Settles Shareholder Suits Over Gentiva Merger
• Regulator Shouldn't Argue For Blue Cross, Fund Says
• Metabolite Says LabCorp Must Pay Up After IP Re-Exam
• HHS Wants Health Insurers To Justify Rate Hikes
• Cleary Gottlieb Reps DSM In $1B Martek Acquisition
• DOJ Says SAIC Decision Supports Blackstone FCA Case
• Senate Sends Short-Term Spending Bill To House
• Wyeth Beats W.Va. Fraud Suit Over Hormone Drugs
• Judge Nixes Mass. Hospital Workers' State Law Claims
• Wyeth Loses Bid To Take Novartis IP Suit To Calif.
• Dey To Pay $280M To End Drug Price Inflation Suit
• US Aims To Protect Scientists From Politics
• Bill Seeks Overhaul Of Global Drug Safety Rules
• Cobalt Defense Nixed In Suit Over Generic Boniva
• Dow Corning Gets Breast Implant Win In 6th Circ.
• NYC Settles Jewish Nurse's Bias Claims
• Oracle Drug Software Infringes Patent, Suit Says
• ACO Payment Methods: The Middle Path Is Best
• Staff Atty, OPM Battle Over Same-Sex Spouse Benefits
• Issa Seeks FDA Probe Into Maker Of Recalled Rolaids
• Bilski Doesn't Doom Prometheus Patents: Fed. Circ.
• Ex-CV Sales Rep Drops Ranexa Marketing Suit
• Pharma Co. Says Insurer Owes It For Reactor Shutdown
• Aflac Faces Class Action Over Ineligible Premiums
• FDA Finds Quality Breaches At J&J Drug Plant
• Mylan Faces Suit Over Orapred ANDA
• GAO Denies Protest Over Iraq Health Care Contract
• Health Providers' New Compensation Deduction Limit
• Blue Cross Michigan Calls DOJ Antitrust Suit Flawed
• Contraceptive Makers Denied Quick End To Patent Suit
• Novo, Sandoz Reach Deal Over Generic Prandin
• Senate Scraps $1.1T Spending Bill
• Bioethics Panel OKs Synthetic Bio, Urges Oversight
• Siemens Partially Off Hook In Lab Test Patent Suit
• Medicis Hits Nycomed Unit With 3rd Vanos Patent Suit
• Fen-Phen Atty Deserved Policy Rescission: Insurer
• La. Judge Scraps Blue Cross HMO State Contract
• FTC Urges 11th Circ. To Revive Pay-For-Delay Case
• US Criticizes Planned Parenthood In Overbilling Case
• Generics Cos. Prevail In AstraZeneca's Crestor Suit
• Case Study: FTC V. Ovation
• HoMedics Didn't Infringe Scale Patent: Fed. Circ.
• Feds Defend 10-Year Sentence For InterMune Exec
• Elan, Eisai To Pay $214M Over Zonegran Marketing
• FDA Moves To Pull Breast Cancer Approval For Avastin
• Pfizer Wins OK For $75M Deal In Shareholder Suits
• Fed. Circ. Kills Tribe's Suit Over Health Care Deficit
• Stryker Sues Zimmer Over Wound System Patent
• FDA Warns Of Hidden Ingredients In Supplements
• Feds Reverse Course, Intervene In Guidant FCA Suit
• NY State Sen., Son Plead Not Guilty To Embezzlement
• Teva's $70M ARS Suit V. Deutsche Tossed For Good
• Covidien Unit Targets Watson Over Generic Exalgo
• Senate Unveils $1.1T Omnibus Spending Bill
• Illumina Suit Over Gene Tech Patents Gets The Boot
• Novartis Finishes Up $51.6B Alcon Purchase
• 3rd Circ. Won't Revive Cephalon Shareholder Case
• Fla. Court Affirms $28.3M RJ Reynolds Verdict
• FDA Warns Airgas Over Poor Records, Contamination
• No Double Jeopardy In Atty Fraud Suit: 5th Circ.
• J&J Hit With $50M Verdict In Pa. Medicare Suit
• Skadden Reps HCP In $6.1B Nursing Home Deal
• 6th Circ. Tosses Supplement Tycoon's 25-Year Stint
• Teva Settles In Bayer Suit Over Generic Yaz
• DOJ Fights Virginia Health Care Ruling In 4th Circ.
• Ex-Professor Can't Toss St. John's Drug Research Suit
• Matrixx To Pay $15.5M In Zicam MDL
• Purdue Execs Can't Shake Ban From Federal Funds
• Judge OKs $27M Deal In Cooper Securities Action
• Vitamin Maker To Pay FDA $2M Over Health Claims
• Mylan Asks High Court To Review Generics Rulings
• 8th Circ. Shuts Down Medtronic ERISA Action
• Calif. Regulator Blocks PacifiCare Dividend
• Galderma Offers $978M For Sweden's Q-Med
• InSight Seeks To Cut Debt By $290M In New Ch. 11
• High Court Won't Consider Medical Device Case
• AntiCancer Sues Cellsight Over Tumor Detection IP
• Congress Can't Require Health Insurance, Judge Says
• Supreme Court Seeks US Input On Definiteness
• Supreme Court To Rule On Generics Labeling Laws
• MMSEA And Product Liability Claims
• Ex-Canopy CEO Admits To Wire Fraud In $93M Scheme
• Blue Cross, Others Booted In Pfizer Neurontin MDL
• Cornell Fails To Nix Verdict In AIDS Research Suit
• Japan Orders J&J To Nix Acuvue Price-Display Ban
• Settlement OK'd In UPS Retirees' Insurance Rate Action
• HHS Clamps Down On Mini-Med Insurance Plans
• Molecular Insight Enters Ch. 11 With $45M Finance Plan
• 2 Accused In Sequenom, EXAS Insider Trading Case
• Kirkland Advises CHS In $3.3B Bid For Tenet
• VNUS Wins $45M Jury Verdict In Medical Laser IP Suit
• Morrison Cohen Reps North Castle In Atkins Sale
• Pfizer Used Corruption Info To Pressure Official: Cable
• Humana Drops Walgreen Drug Plan Comparisons Suit
• Mental Health: Fair Game In Disability Cases?
• Pfizer Pulls Hypertension Drug Thelin From Market
• Fed. Circ. Nixes ERBE's Latest Endoscopy IP Suit
• Feds Subpoena Medtronic Over Neurostimulator Sales
• J&J Unit Recalls 13M Packages Of Rolaids
• Appeals Board Keeps Lockheed Contract Suit Alive
• NJ Doctors To Take Health Reform Suit To 3rd Circ.
• Senate Republicans Block 9/11 Health Bill
• Whistleblower Suit Over Bone Growth Device Stays Put
• 6th Circ. Affirms Toss Of Blue Cross ERISA Action
• Senate Delays Medicare Cuts To Doctor Rates By 1 Year
• 4th Circ. Affirms UK Jurisdiction In Contract Spat
• J&J Hit With $1.8M Verdict In Levaquin MDL
• 6 Cases Move Forward In Novartis MDL Over Bone Drugs
• Sales Rep Hits Merck With Overtime Class Action
• EU Fines French Pharmacists €5M For Price-Fixing
• The Long Arm Of The FTC Reaches Even Approved Deals
• Cravath Reps J&J In $2.3B Bid For Crucell
• 4 More Charged In Alleged $14.5M Medicare Fraud
• Exactech To Pay $3M To Settle Kickbacks Case
• SEC, DOJ Sue MediSys Over Alleged Kickback Schemes
• Ark. Court Backs Class Cert. For Insurance Customers
• Abbott, Others To Pay $421M Over Drug Price Hikes
• Medicare Stent Scam Cost $3.8M, Senate Report Says
• Cipro Buyers Urge High Court To Rule On Pay-For-Delay
• Fla. Workers Win Class Cert. In Wellness Program Suit
• 9th Circ. Nixes En Banc Bid In Humana Marketing Suit
• Philips' Suit Over Defibrillator Patent Stays Alive
• Aetna To Scoop Up Health Tech Co. Medicity For $500M
• Reckitt, Watson Drop Patent In Suit Over Mucinex ANDA
• The End Of Class Actions? Not Likely
• Pfizer Proposes $75M Fund To Settle Shareholder Suits
• Pfizer Wins Verdict In Suit Over Prempro-Cancer Link
• Judge Tosses Cigna Case Managers' FLSA Class Action
• DOI To Rethink Bids On $30M Health IT Contract
• Pharmacy Drops Provigil Class Suit Against Cephalon
• Cigna Wins Toss Of Disability Plan Class Action
• Case Study: Nightingale V. Anodyne
• Humana Sues Walgreen Over Drug Cost Comparisons
• Shire Sues Impax, Watson Over Generic Intuniv
• McNeil Asks High Court To Review Drug Failure To Warn
• GAO Upholds Cigna's $248M Medicare Contract
• Mount Sinai Hospital Official Cops To Bid-Rigging
• 15-Year Sentence Reinstated For National Century Exec
• Judge Tosses Part Of Ex-Wyeth Exec's Firing Suit
• Mayo Sues BP To Collect Oil, Gas Royalties
• What To Do When Seed Money Gets Personal
• EU Antitrust Raids Target AstraZeneca
• Allergan False Marking Case Survives Dismissal Bid
• Healthways To Settle ERISA Class Action For $1.25M
• AstraZeneca Seeks To Halt Mylan's 2nd Seroquel ANDA
• Stryker Loses Bid To Toss Pain Pump Suits
• Momenta, Sandoz Sue Teva Over Lovenox Generic
• RJ Reynolds Agrees To Meet With AGs On Marketing
• J&J Recalls Mylanta To Revise Alcohol Labeling
• Health Provider Loses Cert. Bid In State Farm Suit
• Univ. Of Wash. Targets GE Over Ultrasound Patent
• Ex-GSK Atty Pleads Not Guilty To FDA Probe Charges
• EU, India Near Settlement In Drug Seizure Row
• CareCore Hit With $34M Verdict In Antitrust Suit
• Mo. Hospitals To Pay $2.2M To Settle FCA Claims
• Liberty University Aims To Revive Health Care Suit
• FTC Challenges LabCorp's Westcliff Acquisition
• DOJ, FTC Chided For Insurance Antitrust Efforts
• Novo Patent Fight Over Prandin To Stay In Minn.
• Plaintiffs Exit Bayer MDL But Still Face Discovery
• Ropes & Gray Reps Axcan In $583M Eurand Deal
• The SEC's Lessons For Medical Consultants